Culturally-Tailored Smoking Cessation for Adult American Indian Smokers: A Clinical Trial.

Abstract

This collaborative, community-engaged project developed and tested a Culturally-Tailored Treatment (CTT) for American Indian/Alaska Native (AI/AN) smokers in the Menominee tribal community. One hundred three adult AI/AN smokers were randomized to receive either Standard Treatment (n= 53) or CTT (n = 50) for smoking cessation. Both treatment conditions included 12 weeks of varenicline and four individual counseling sessions but differed in terms of cultural tailoring of the counseling. The primary outcome was 7-day biochemically-confirmed point-prevalence abstinence (PPA) at the 6-month end-of-study visit. Both intention-to-treat (ITT) and responder-only analyses were conducted. There were no statistically significant group differences in 7-day PPA. The overall ITT abstinence rate at 6 months was 20%; the responder-only rate was 42%. The current study represents the first randomized smoking cessation clinical trial testing a culturally-tailored smoking cessation intervention designed for a specific AI/AN tribal community that combined FDA-approved cessation medication (varenicline) and innovative cultural intervention components.

6 Figures and Tables

Cite this paper

@article{Smith2014CulturallyTailoredSC, title={Culturally-Tailored Smoking Cessation for Adult American Indian Smokers: A Clinical Trial.}, author={Stevens S. Smith and Leah M Rouse and Mark Caskey and Jodi Fossum and R. K. Strickland and J Kevin Culhane and Jerry Waukau}, journal={The Counseling psychologist}, year={2014}, volume={42 6}, pages={852-886} }